» Articles » PMID: 37928705

First-in-human In-vivo Depiction of Paraganglioma Metabolism by Hyperpolarised C-magnetic Resonance

Abstract

Phaeochromocytomas (PCC) and paragangliomas (PGL), cumulatively referred to as PPGLs, are neuroendocrine tumours arising from neural crest-derived cells in the sympathetic and parasympathetic nervous systems. Predicting future tumour behaviour and the likelihood of metastatic disease remains problematic as genotype-phenotype correlations are limited, the disease has variable penetrance and, to date, no reliable molecular, cellular or histological markers have emerged. Tumour metabolism quantification can be considered as a method to delineating tumour aggressiveness by utilising hyperpolarised C-MR (HP-MR). The technique may provide an opportunity to non-invasively characterise disease behaviour. Here, we present the first instance of the analysis of PPGL metabolism via HP-MR in a single case.

References
1.
Hill D, Orton M, Mariotti E, Boult J, Panek R, Jafar M . Model free approach to kinetic analysis of real-time hyperpolarized 13C magnetic resonance spectroscopy data. PLoS One. 2013; 8(9):e71996. PMC: 3762840. DOI: 10.1371/journal.pone.0071996. View

2.
Tran M, Latifoltojar A, Neves J, Papoutsaki M, Gong F, Comment A . First-in-human non-invasive assessment of intra-tumoral metabolic heterogeneity in renal cell carcinoma. BJR Case Rep. 2019; 5(3). PMC: 6699984. DOI: 10.1259/bjrcr.20190003. View

3.
Baez J, Jagannathan J, Krajewski K, ORegan K, Zukotynski K, Kulke M . Pheochromocytoma and paraganglioma: imaging characteristics. Cancer Imaging. 2012; 12:153-62. PMC: 3362869. DOI: 10.1102/1470-7330.2012.0016. View

4.
Abeyakoon O, Latifoltojar A, Gong F, Papoutsaki M, Chowdhury R, Glaser M . Hyperpolarised C MRI: a new horizon for non-invasive diagnosis of aggressive breast cancer. BJR Case Rep. 2019; 5(3):20190026. PMC: 6750630. DOI: 10.1259/bjrcr.20190026. View

5.
Nelson S, Kurhanewicz J, Vigneron D, Larson P, Harzstark A, Ferrone M . Metabolic imaging of patients with prostate cancer using hyperpolarized [1-¹³C]pyruvate. Sci Transl Med. 2013; 5(198):198ra108. PMC: 4201045. DOI: 10.1126/scitranslmed.3006070. View